BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chen GX, Zheng LH, Liu SY, He XH. rAd-p53 enhances the sensitivity of human gastric cancer cells to chemotherapy. World J Gastroenterol 2011; 17(38): 4289-4297 [PMID: 22090785 DOI: 10.3748/wjg.v17.i38.4289]
URL: https://www.wjgnet.com/1007-9327/full/v17/i38/4289.htm
Number Citing Articles
1
Hangjun Gong, Yu Cao, Gang Han, Yun Zhang, Qing You, Yidong Wang, Yamin Pan. p53/microRNA-374b/AKT1 regulates colorectal cancer cell apoptosis in response to DNA damageInternational Journal of Oncology 2017; 50(5): 1785 doi: 10.3892/ijo.2017.3922
2
Diana Costa, Artur J. M. Valente, João Queiroz. HydrogelsGels Horizons: From Science to Smart Materials 2018; : 339 doi: 10.1007/978-981-10-6077-9_13
3
Renzhi Yu, Minghuan Wang, Xiuli Zhu, Zhe Sun, Aiying Jiang, Huixin Yao. Therapeutic effects of lenvatinib in combination with rAd‑p53 for the treatment of non‑small cell lung cancerOncology Letters 2018;  doi: 10.3892/ol.2018.9428
4
Junior A. Enow, Hummad I. Sheikh, Masmudur M. Rahman. Tumor Tropism of DNA Viruses for Oncolytic VirotherapyViruses 2023; 15(11): 2262 doi: 10.3390/v15112262
5
Qi Xie, Min-Yi Wu, Ding-Xuan Zhang, Yi-Ming Yang, Bao-Shuai Wang, Jing Zhang, Jin Xu, Wei-De Zhong, Jia-Ni Hu. Synergistic anticancer effect of exogenous wild-type <i>p53</i> gene combined with 5-FU in human colon cancer resistant to 5-FU <i>in vivo</i>World Journal of Gastroenterology 2016; 22(32): 7342-7352 doi: 10.3748/wjg.v22.i32.7342
6
Diana Costa, Artur J.M. Valente, M. Graça Miguel, João Queiroz. Plasmid DNA hydrogels for biomedical applicationsAdvances in Colloid and Interface Science 2014; 205: 257 doi: 10.1016/j.cis.2013.08.002
7
Yong-Hua Xu, Shuo-Hui Liu, Fu-Rong Hao, Yin-Huan Zhang. Recombinant adenovirus p53 combined with radiotherapy improves efficacy and safety in the treatment of head and neck lymphomaCancer Biomarkers 2018; 23(2): 213 doi: 10.3233/CBM-181286
8
Li Qi, Guiqing Li, Peipei Li, Hongwei Wang, Xiaolong Fang, Tongchuan He, Jingjing Li. Twenty years of Gendicine® rAd-p53 cancer gene therapy: The first-in-class human cancer gene therapy in the era of personalized oncologyGenes & Diseases 2024; 11(4): 101155 doi: 10.1016/j.gendis.2023.101155
9
Jiawei Guo, Weiwei Yu, Hui Su, Xiufeng Pang. Genomic landscape of gastric cancer: molecular classification and potential targetsScience China Life Sciences 2017; 60(2): 126 doi: 10.1007/s11427-016-0034-1
10
Ling-yan Jiang, Meng Lian, Hong Wang, Ju-gao Fang, Qi Wang. Inhibitory effects of 5-Aza-2′-deoxycytidine and trichostatin A in combination with p53-expressing adenovirus on human laryngocarcinoma cellsChinese Journal of Cancer Research 2012; 24(3): 232 doi: 10.1007/s11670-012-0232-6
11
Xiaoyong Fan, Hongzhen Lu, Youqiang Cui, Xianzeng Hou, Chuanjiang Huang, Guangcun Liu. Overexpression of p53 delivered using recombinant NDV induces apoptosis in glioma cells by regulating the apoptotic signaling pathwayExperimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.5935
12
Sabino Russi, Henu Kumar Verma, Simona Laurino, Pellegrino Mazzone, Giovanni Storto, Anna Nardelli, Pietro Zoppoli, Giovanni Calice, Francesco La Rocca, Alessandro Sgambato, Valeria Lucci, Geppino Falco, Vitalba Ruggieri. Adapting and Surviving: Intra and Extra-Cellular Remodeling in Drug-Resistant Gastric Cancer CellsInternational Journal of Molecular Sciences 2019; 20(15): 3736 doi: 10.3390/ijms20153736
13
Tuo Ruan, Weizhen Liu, Kaixiong Tao, Chuanqing Wu. <p>A Review of Research Progress in Multidrug-Resistance Mechanisms in Gastric Cancer</p>OncoTargets and Therapy 2020; : 1797 doi: 10.2147/OTT.S239336
14
Jie Xiao, Jian Zhou, Min Fu, Li Liang, Qiaoling Deng, Xiaoyun Liu, Fumin Liu. Efficacy of recombinant human adenovirus-p53 combined with chemotherapy for locally advanced cervical cancer: A clinical trialOncology Letters 2017; 13(5): 3676 doi: 10.3892/ol.2017.5901
15
Hailong Zhang, Yixuan Hou, Liyun Xu, Zongyue Zeng, Siyang Wen, Yan-e Du, Kexin Sun, Jiali Yin, Lei Lang, Xiaoli Tang, Manran Liu. Cytoplasmic Drosha Is Aberrant in Precancerous Lesions of Gastric Carcinoma and Its Loss Predicts Worse Outcome for Gastric Cancer PatientsDigestive Diseases and Sciences 2016; 61(4): 1080 doi: 10.1007/s10620-015-3986-0
16
Hai‑Bo Qiao, Jia Li, Lian‑Jie Lv, Ben‑Jin Nie, Peng Lu, Feng Xue, Zhi‑Ming Zhang. The effects of interleukin 2 and rAd-p53 as a treatment for glioblastomaMolecular Medicine Reports 2018;  doi: 10.3892/mmr.2018.8408
17
Wei-Wei Zhang, Longjiang Li, Dinggang Li, Jiliang Liu, Xiuqin Li, Wei Li, Xiaolong Xu, Michael J. Zhang, Lois A. Chandler, Hong Lin, Aiguo Hu, Wei Xu, Dominic Man-Kit Lam. The First Approved Gene Therapy Product for Cancer Ad-p53(Gendicine): 12 Years in the ClinicHuman Gene Therapy 2018; 29(2): 160 doi: 10.1089/hum.2017.218
18
Anais Blanchet, Agathe Bourgmayer, Jean-Emmanuel Kurtz, Georg Mellitzer, Christian Gaiddon. Isoforms of the p53 Family and Gastric Cancer: A Ménage à Trois for an Unfinished AffairCancers 2021; 13(4): 916 doi: 10.3390/cancers13040916
19
Diana Costa, Artur J.M. Valente, João Queiroz. Handbook of Polymers for Pharmaceutical Technologies2015; : 145 doi: 10.1002/9781119041559.ch6
20
Henu Kumar Verma, Geppino Falco, L. V. K. S. Bhaskar. Theranostics Approaches to Gastric and Colon CancerDiagnostics and Therapeutic Advances in GI Malignancies 2020; : 117 doi: 10.1007/978-981-15-2017-4_8
21
Shao Wen Xiao, Yi-Zhi Xu, Bu-Fan Xiao, Jing Jiang, Chang-Qing Liu, Zhi-wei Fang, Dong-Ming Li, Xiao Fan Li, Yong Cai, Yong Heng Li, Yan Sun, Xing Su, Guang-Ying Zhu, Shan Wen Zhang. Recombinant Adenovirus-p53 Gene Therapy for Advanced Unresectable Soft-Tissue SarcomasHuman Gene Therapy 2018; 29(6): 699 doi: 10.1089/hum.2017.103